von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension.

Kawut SM, Horn EM, Berekashvili KK, Widlitz AC, Rosenzweig EB, Barst RJ

Effects of long-term bosentan in children with pulmonary arterial hypertension.

Rosenzweig EB, Ivy DD, Widlitz A, Doran A, Claussen LR, Yung D, Abman SH, Morganti A, Nguyen N, Barst RJ

Idiopathic pulmonary arterial hypertension in children.

Rosenzweig EB, Barst RJ

New predictors of outcome in idiopathic pulmonary arterial hypertension.

Kawut SM, Horn EM, Berekashvili KK, Garofano RP, Goldsmith RL, Widlitz AC, Rosenzweig EB, Kerstein D, Barst RJ

Outcomes in children with idiopathic pulmonary arterial hypertension.

Yung D, Widlitz AC, Rosenzweig EB, Kerstein D, Maislin G, Barst RJ

Pulmonary arterial hypertension in children.

Rosenzweig EB, Widlitz AC, Barst RJ

Pulmonary hypertension in Jarcho-Levin syndrome.

Rastogi D, Rosenzweig EB, Koumbourlis A

Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery.

Rosenzweig EB, Starc TJ, Chen JM, Cullinane S, Timchak DM, Gersony WM, Landry DW, Galantowicz ME

Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.

Rosenzweig EB, Kerstein D, Barst RJ